SRNT is the only international scientific society dedicated to fostering and disseminating research on tobacco and nicotine logo Society for the Study of Addiction
* see translation disclaimer below
Some key links

Areas for further research

  • Development of effective pharmacotherapies based on a basic science understanding of the effects of nicotine and the nicotinic receptor.
  • Development of more precise behavioural accounts of smoking that suggest more specific behavioural interventions.
  • Identify elements/components of behavioural interventions that will enhance effectiveness. 
  • Find ways of enabling healthcare professionals to deliver routine opportunistic advice to stop smoking more often. 
  • Investigate the effectiveness of combining NRT and non-nicotine pharmacotherapies. .
  • Investigate tailoring of pharmacotherapies to smoker characteristics.
  • Investigate long-term use of pharmacotherapies to prevent relapse to smoking. 
  • Investigate effect of continuing pharmacological or behavioural treatment after a lapse to prevent relapse.
  • Investigate use of pharmacotherapies in pregnancy.
  • Investigate whether use of NRT during temporary abstinence increases or decreases motivation to quit.
  • Investigate long-term use of NRT or other pharmacotherapies as a harm reduction strategy to reduce the amount smoked. 
  • Identify the most effective forms and components of behavioural smoking reduction interventions as a means to ultimately quit smoking.
  • Investigate 
  • the potential health benefits of PREPs and tobacco harm reduction approaches.
  • Develop and test interventions for adolescent smokers. 
  • Find ways of improving access to effective interventions. 
  • Identify organizational features of healthcare systems that support the delivery of appropriate interventions. 
  • Investigate repeated interventions for relapsers.
  • Investigate treatment of smokers with co-morbidities (psychiatric illness, other chemical dependencies).
  • Investigate proactive methods to prompt more smokers to make a quit attempt (e.g. phone calls or mailings).
  • Investigate the efficacy and safety of electronic cigarettes, including in pregnancy
  • Investigate the best ways to educate people effectively about the use of nicotine containing non-tobacco products, in comparison to tobacco products.
  • Investigate the relative efficacy and cost-effectiveness of different smoking cessation interventions.
  • Investigate the most effective interventions for smokers who are part of ‘hard-to-reach groups’.
  • Investigate which interventions are most effective in reducing the difference in the number of smokers in low compared with high socioeconomic groups.
  • Investigate which interventions are the most effective to help people stop smoking in communities where smoking and a group has cultural and social value.
  • Investigate how we can encourage and help mental health workers to o­ffer stop smoking services to patients with mental illness.
  • Investigate the most e­ffective and cost-e­ffective ways to help people with mental health problems to quit smoking inside and outside of mental health treatment settings.
  • Investigate the most eff­ective and cost-eff­ective way to help people who also have drug and alcohol problems to quit smoking
  • Identify the most eff­ective way to prompt people to quit smoking.
  • Identify the most e­ffective and cost-eff­ective methods pregnant smokers can use to give up smoking.
  • Investigate methods to ensure all healthcare providers provide cessation treatment that has been found to be e­ffective, safe & cost-eff­ective.
  • Identify the types of health providers who provide the most e­ffective support to help people to quit smoking, and how much training they need to be most e­ffective
  • Identify the most e­ffective interventions that can be used in primary care (e.g. doctors’ and dentists’ surgeries, pharmacies) to encourage more people to use stop smoking services and to give up smoking. logo
Home | Sitemap